Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes

Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes

Conditions: Type1 Diabetes Mellitus; Adiposity
Interventions: Procedure: Euglycemic hyperinsulinemic clamp with tracer enhancement; Procedure: Euglycemic hyperinsulinemic clamp with tracer enhancement
Sponsors: Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 4, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments